Orgenesis Mobile Processing Units and Labs (OMPULs) to be Used for Point-of-Care Production and Commercialization of Cell and Gene Therapies in Collaboration with Dong-a University Hospital and Cure T
Go back to Orgenesis Mobile Processing Units and Labs (OMPULs) to be Used for Point-of-Care Production and Commercialization of Cell and Gene Therapies in Collaboration with Dong-a University Hospital and Cure T| Orgenesis, Inc. NEW (NASDAQ: ORGS) | Delayed: 0.50 -0.02 (3.85%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.52 | 52 Week High | $0.52 | |||
| Open | $0.52 | 52 Week Low | $0.24 | |||
| Day High | $0.52 | P/E | 10.00 | |||
| Day Low | $0.50 | EPS | $0.05 | |||
| Volume | 35,557 | |||||
